Pw. Mantyh et al., BETA(2)-ADRENERGIC RECEPTORS ARE EXPRESSED BY GLIA IN-VIVO IN THE NORMAL AND INJURED CENTRAL-NERVOUS-SYSTEM IN THE RAT, RABBIT, AND HUMAN, The Journal of neuroscience, 15(1), 1995, pp. 152-164
Previous studies have demonstrated that glial cells in culture express
several subtypes of functional adrenergic receptors. To determine if
similar receptors are expressed by glia in vivo, we examined the expre
ssion of adrenergic receptors in the normal, crushed, and transected o
ptic nerves of the rabbit and rat using quantitative receptor autoradi
ography. Additionally, we examined the expression of adrenergic recept
ors in the normal and damaged human optic nerve. High levels of alpha(
1)-, alpha(2)-, beta(1)-, and beta(2)-adrenergic receptors were identi
fied in the rabbit and rat forebrain. In the normal rabbit, rat, and h
uman optic nerves, only alpha(1) beta(2) receptors were observed, and
these were present in low to moderate densities. Combined immunohistoc
hemistry and autoradiography suggests that the majority of beta(2)-adr
energic receptors in the rabbit, rat, and human optic nerve are expres
sed by astrocytes. After unilateral optic nerve crush or transection,
only beta(2) adrenergic receptors were significantly increased. This i
ncrease in beta(2) receptors was first detectable at days 7 and 28 pos
t-transection in the rabbit and rat, respectively. The expression of b
eta(2) receptors in the transected optic nerve continued to increase w
ith time, so that by 90 d post-transection the density of beta(2) rece
ptors in both the rabbit and rat optic nerve was among the highest of
any area in the forebrain. Taken together with previous studies, these
results suggest that in vivo, beta(2)-adrenergic receptors may provid
e a therapeutic target for regulation of astrocyte functions including
glycogen metabolism, cytokine release, and the hypertrophy and prolif
eration that occurs in response to neuronal injury.